의인성 크로이츠펠트-야콥병 예방을 위한 공공 관리
Public Action for Prevention of Iatrogenic Transmission Of
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
CreutzfeldtJakob Disease (CJD) is a rare and a rapidly progressive, invariably fatal neurodegenerative disorder believed to be caused by an abnormal isoform of a cellular glycoprotein known as the prion protein. The disease develops in very different ways, such as sporadic, familial, and iatrogenic. Although there is no means to prevent sporadic and familial CJD outbreaks, iatrogenic CJD can be prevented since the iatrogenic transmission pathway to human is mostly identified. However, despite its public health importance, there is no practical laboratory method for diagnosing this disease in an asymptomatic state. Therefore, it is very important to track the infection route one by one and act public preventive measure. However, there are no manual for prevention of iatrogenic transmission of this disease in Korea. Accordingly, this review summarizes on how to evaluate and act on surgical incidents that occurred in patients with CJD or highrisk patients. However, this is not an easy task for public health management teams as this field continues to require new scientific or specialized clinical knowledge. Therefore, a group or organization of expert panels is needed to manage and make decisions in general. Finally, this review was made with reference to the management regulations of countries with widespread exposure to CJD, including variant CJD. In other words, it is a very conservative and strict safetyoriented guideline. However, since the surveillance of diseases must take into each national medical situation and economic burden, some readjustments are necessary to the situation of the Republic of Korea.
Abstract
CreutzfeldtJakob Disease (CJD) is a rare and a rapidly progressive, invariably fatal neurodegenerative disorder believed to be caused by an abnormal isoform of a cellular glycoprotein known as the prion protein. The disease develops in very different ways, such as sporadic, familial, and iatrogenic. Although there is no means to prevent sporadic and familial CJD outbreaks, iatrogenic CJD can be prevented since the iatrogenic transmission pathway to human is mostly identified. However, despite its public health importance, there is no practical laboratory method for diagnosing this disease in an asymptomatic state. Therefore, it is very important to track the infection route one by one and act public preventive measure. However, there are no manual for prevention of iatrogenic transmission of this disease in Korea. Accordingly, this review summarizes on how to evaluate and act on surgical incidents that occurred in patients with CJD or highrisk patients. However, this is not an easy task for public health management teams as this field continues to require new scientific or specialized clinical knowledge. Therefore, a group or organization of expert panels is needed to manage and make decisions in general. Finally, this review was made with reference to the management regulations of countries with widespread exposure to CJD, including variant CJD. In other words, it is a very conservative and strict safetyoriented guideline. However, since the surveillance of diseases must take into each national medical situation and economic burden, some readjustments are necessary to the situation of the Republic of Korea.
참고문헌 (13)
- Johnson R, "Prion diseases", Lancet Neurol, 4, pp.635~642 (2005)
- Smith PG, "Bovine spongiform encephalopathy(BSE)and its epidemiology", Br Med Bull, 66, pp.185~198 (2003)
- Bernoulli C, "Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery", Lancet, 1, pp.478~479 (1977)
- Llewelyn CA, "Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion", Lancet, 363, pp.417~421 (2004)
- Duffy P, "Letter : possible person-to-person transmission of Creutzfeldt-Jakob disease", N Engl J Med, 290, pp.692~693 (1974)
- 김혜림, "Dura Mater Graft-Associated Creutzfeldt-Jakob Disease: The First Case in Korea", Journal of Korean Medical Science, 26(11), pp.1515~1517 (2011), 대한의학회
- Lee SY, "Surveillance of Creutzfeldt-Jakob disease(CJD)patients in the republic of Korea, 2016-2019", PHWR, 13, pp.1796~1807 (2020)
- Ae R, "Update : dura mater graft-associated Creutzfeldt-Jakob disease-Japan, 1975-2017", MMWR Morb Mortal Wkly Rep, 67, pp.274~278 (2018)
- Ryan R, "Notification and support for people exposed to the risk of Creutzfeldt-Jakob disease(CJD)(or other prion diseases)through medical treatment(iatrogeni-cally)", Cochrane Database Syst Rev, 16, pp.CD007578~ (2011)
- "Public Health England. Public health action following a report of a new case of CJD or a person at increased risk of CJD"[URL]
- Hall V, "Managing the risk of iatrogenic transmission of Creutzfeldt-Jakob disease in the UK", J Hosp Infect, 88, pp.22~27 (2014)
- "creutzfeldt-Jakob disease guidance manual" (2021)[URL]
- Watson N, "The importance of ongoing international surveillance for Creutzfeldt-Jakob disease", Nat Rev Neurol, 17, pp.362~379 (2021)